Terminal · Institutions

Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.

Carlyle Group Inc. 13F Holdings -- Portfolio & Top Positions (2026-03-31)

Carlyle Group Inc. (CIK 1527166) reported $10.62B across 18 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: ($8.33B, 78.40%), SARO ($2.18B, 20.58%), PHAT ($38.8M, 0.37%), PONY ($22.3M, 0.21%), INVH ($16.5M, 0.16%). Source: SEC Form 13F.

RankTickerCompanyValue% PortfolioSharesAction
1Medline Inc$8.33B78.40%187.1MTrimmed
2SAROStandardaero Inc$2.18B20.58%84.6MTrimmed
3PHATPhathom Pharmaceuticals Inc$38.8M0.37%3.5MHold
4PONYPony Ai Inc$22.3M0.21%2.4MHold
5INVHInvitation Homes Inc$16.5M0.16%664,100Hold
6CUBECubeSmart$8.1M0.08%220,500Hold
7QTTBQ32 Bio Inc$7.1M0.07%1.1MHold
8GETYGetty Images Holdings Inc$4.9M0.05%6.2MHold
9FWRDForward Air Corp$1.8M0.02%107,214Hold
10SPRBSpruce Biosciences Inc$2.5M0.02%38,620Hold
11ACETAdicet Bio Inc$1.3M0.01%184,295Hold
12SPWRSunPower Inc$550,1110.01%433,158Hold
13JSPRJasper Therapeutics Inc$934,1950.01%1.1MHold
14DNUTKrispy Kreme Inc$1.2M0.01%340,748Hold
15OKUROnkure Therapeutics Inc$1.1M0.01%269,895Hold
16SYRESpyre Therapeutics Inc$485,2330.00%9,620Hold
17XCURExicure Inc$239,6470.00%56,328Hold
18Heartflow Inc$497,2560.00%20,438New
19NABLN-able Inc$437,7280.00%93,732Hold
20NCNANucana Plc$00.00%0Exited
21HOODRobinhood Mkts Inc$233,9570.00%3,376Hold

Source: SEC Form 13F filings · as of 2026-03-31